Bioactivity and toxicity studies of amphotericin B incorporated in liquid crystals

European Journal of Pharmaceutical Sciences

Volumn 43, Issue 4, 2011, Pages 308-317

  Chuealee, Rabkwan ^a   Aramwit, Pornanong ^b   Noipha, Kusumarn ^a,c   Srichana, Teerapol ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c THAKSIN UNIVERSITY   (Thailand)

Author keywords

Amphotericin B; Antifungal activity; Cytotoxicity; Hematotoxicity; Liquid crystal

Indexed keywords

AMPHOTERICIN B; CARBONIC ACID DERIVATIVE; CHOLESTERYLPALMITYLCARBONATE; DICHOLESTERYLCARBONATE; DRUG CARRIER; ESTER DERIVATIVE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SODIUM CHOLESTERYL CARBONATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STRUCTURE; DRY POWDER; EPITHELIUM CELL; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; LIQUID CRYSTAL; LUNG ALVEOLUS CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; TOXICITY TESTING;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CELL LINE; CYTOKINES; DRUG CARRIERS; DRY POWDER INHALERS; EPITHELIAL CELLS; ERYTHROCYTES; FUNGI; HUMANS; INTERLEUKIN-1BETA; LIQUID CRYSTALS; MACROPHAGES, ALVEOLAR; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959589171     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.05.009     Document Type: Article

References (34)

1. G.L. Baum, J.D. Crapo, B.R. Celli, and J.B. Karlinsky Textbook of Pulmonary Diseases sixth ed. 1998 Lippincott-Raven Publishers Philadelphia
2. G.W. Beadle, H.K. Mitchell, and D. Bonner Improvements in the cylinder-plate method for penicillin assay J. Bacteriol. 49 1945 101 104
3. I. Bekersky, G.W. Boswell, R. Hiles, R.M. Fielding, D. Buell, and T.J. Walsh Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats Pharm. Res. 17 2000 1494 1502 (Pubitemid 32217558)
4. J. Bolard, M. Seigneuret, and G. Boudet Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence Biochim. Biophys. Acta 599 1980 280 293 (Pubitemid 10026151)
5. A. Bryskier Antimicrobial Agents: Antibacterials and Antifungals 2005 ASM Press Washington, DC
6. R. Chuealee, T.S. Wiedmann, and T. Srichana Thermotropic behavior of sodium cholesteryl carbonate J. Mater. Res. 24 2009 156 163
7. R. Chuealee, T.S. Wiedmann, R. Suedee, and T. Srichana Interaction of Amphotericin B with cholesteryl palmityl carbonate ester J. Pharm. Sci. 99 2010 4593 4602
8. Driscoll, K.E., Maurer, J.K., 1991. Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity. Toxicol. Pathol. 19, 398-405.
9. J.M. Edmondson, L.S. Armstrong, and A.O. Martinez A rapid and simple MTT-based spectrophotometric assay for determining the drug sensitivity in monolayer cultures J. Tissue Cult. Methods 11 1988 15 17
10. J.C. Fantone, and P.A. Ward Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions Am. J. Pathol. 107 1982 395 418
11. R.M. Fielding Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: implications for the characterization of liposomal formulations Pharm. Res. 18 2001 238 242 (Pubitemid 32592605)
12. Forster, D., Washington, C., Davis, S.S., 1988. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocyte. J. Pharm. Pharmacol. 40, 325-328.
13. H. Fukui, T. Koike, A. Saheki, S. Sonoke, Y. Tomii, and J. Seki Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS) Int. J. Pharm. 263 2003 51 60 (Pubitemid 37087932)
14. H.A. Gallis, R.H. Drew, and W.W. Pickard Amphotericin B: 30 years of clinical experience Rev. Infect. Dis. 12 1990 308 329 (Pubitemid 20118658)
15. J. Gavald, M.T. Martín, P. López, X. Gomis, J.L. Ramírez, D. Rodríguez, O. Len, Y. Puigfel, I. Ruíz, and A. Pahissa Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis Antimicrob. Agents Chemother. 49 2005 3028 3030 (Pubitemid 40917634)
16. J.M. Griscavage, N.E. Rogers, M.P. Sherman, and L.J. Ignarro Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide J. Immunol. 151 1993 6329 6337 (Pubitemid 23340379)
17. V. Heinemann, D. Bosse, U. Jehn, A. Debus, K. Wachholz, H. Forst, and W. Wilmanns Enhanced pulmonary accumulation of liposomal amphotericin B (AmBisome) in acute liver transplant failure J. Antimicrob. Chemother. 40 1997 295 297 (Pubitemid 27394028)
18. R.J. Helmke, V.F. German, and J.A. Mangos A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages In Vitro Cell. Dev. Biol. 25 1989 44 48 (Pubitemid 19072625)
19. W.G. Hocking, and D.W. Golde The pulmonary-alveolar macrophage (first of two parts) N. Engl. J. Med. 301 1979 580 587 (Pubitemid 10226453)
20. K. Huttunen, M. Ruotsalainen, E. Iivanainen, P. Torkko, M. Katila, and M. Hirvonen Inflammatory responses in RAW264.7 macrophages caused by mycobacteria isolated from moldy houses Environ. Toxicol. Pharmacol. 8 2000 237 244
21. S. Jullien, and J. Brajtburg Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations Biochim. Biophys. Acta 1021 1990 39 45 (Pubitemid 20047003)
22. M. Jumaa, and B.W. Müller Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect Eur. J. Pharm. Sci. 9 2000 285 290
23. S.H. Jung, D.H. Lim, S.H. Jung, J.E. Lee, K.S. Jeong, H. Seong, and B.C. Shin Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics Eur. J. Pharm. Sci. 37 2009 313 320
24. C.M. Lowry, F.M. Marty, S.O. Vargas, J.T. Lee, K. Fiumara, A. Deykin, and L.R. Baden Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study Transpl. Infect. Dis. 9 2007 121 125 (Pubitemid 46669088)
25. M.R. McGinnis, and M.G. Rinaldi Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biologic fluids V. Lorian, Antibiotics in Laboratory Medicine 1991 Lippincott Williams and Wilkins Baltimore, MD, USA 176 211
26. D.R. Meldrum, B.D. Shames, X. Meng, D.A. Fullerton, R.C. McIntyre Jr., F.L. Grover, and A.H. Harken Nitric oxide downregulates lung macrophage inflammatory cytokine production Ann. Thorac. Surg. 66 1998 313 317 (Pubitemid 28410652)
27. Monforte, V., Ussetti, P., Gavald, J., Bravo, C., Laporta, R., Len, O., García-Gallo, C.L., Tenorio, L., Solé, J., Román, A., 2010. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J. Heart Lung Transplant. 29, 523-530.
28. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
29. U. Persson, G.R. Tennvall, S. Andersson, G. Tyden, and B. Wettermark Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses Pharmacoeconomics 2 1992 500 508
30. K. Punturee, C.P. Wild, and U. Vinitketkumneun Thai medicinal plants modulate nitric oxide and tumor necrosis factor-alpha in J774.2 mouse macrophages J. Ethnopharmacol. 95 2004 183 189 (Pubitemid 39422668)
31. S.P. Shah, and A. Misra Development of liposomal amphotericin B dry powder inhaler formulation Drug. Deliv. 11 2004 247 253 (Pubitemid 39096043)
32. 3 receptors: stimulation of IL-10 production J. Immunol. 164 2000 2964 2970 (Pubitemid 30148954)
33. United States Pharmacopeia (USP 29, NF 24), 2006. Guideline No. 66: Antibiotics-Microbial Assays. US Pharmacopeial Convention, Inc., Rockville, MD.
34. N.M. Witzke, and R. Bittman Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphatidylcholine/sterol vesicles Biochemistry 23 1984 1668 1674